{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T05:23:22Z","timestamp":1792041802162,"version":"4.4.0"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T00:00:00Z","timestamp":1712102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Stroke"],"abstract":"<jats:p>While tyrosine kinase inhibitors (TKI)-associated cerebral vascular stenosis (CVS) exhibit distinct mechanisms compared to conventional stroke in basic research, the clinical strategy remains nearly the same other than TKI-switching. We present the case of a 22-year-old female with chronic myeloid leukemia without stroke risk factors, who developed ponatinib-associated CVS. Three potential characteristics of TKI-associated CVS were identified: a heightened threshold for infarction, an atypical infarct area, and vascular recoverability. Specifically, brain computed tomography remained normal despite 20 h of severe hemiplegia. The ischemic distribution was confined in gray matter and the anterior cerebral artery territory on magnetic resonance imaging, despite severe stenosis of the internal carotid artery. Ischemic changes resolved within 10 days and arterial stenosis improved after ponatinib withdrawal. These unique features, distinct from typical stroke, could lead to misdiagnosis as non-organic neurological disorders or other conditions in ponatinib-treated patients.<\/jats:p>","DOI":"10.3389\/fstro.2024.1367869","type":"journal-article","created":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T04:37:06Z","timestamp":1712119026000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Case report: Three characteristics of tyrosine kinase inhibitor-associated cerebrovascular stenosis. High threshold for infarction, atypical infarct area, and vascular recoverability under the use of ponatinib"],"prefix":"10.3389","volume":"3","author":[{"given":"Akira","family":"Hanazono","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masamichi","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuntaro","family":"Togashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruko","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashiro","family":"Sugawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,4,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.redox.2017.01.007","article-title":"Angiogenesis in the atherosclerotic plaque","volume":"12","author":"Camar\u00e9","year":"2017","journal-title":"Redox Biol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1177\/0271678X17744453","article-title":"Thresholds for infarction vary between gray matter and white matter in acute ischemic stroke: a CT perfusion study","volume":"39","author":"Chen","year":"2019","journal-title":"J. Cereb. Blood Flow Metab"},{"key":"B3","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1136\/jnnp.2009.181487","article-title":"The different infarct patterns between adulthood-onset and childhood-onset moyamoya disease","volume":"82","author":"Cho","year":"2011","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B4","doi-asserted-by":"publisher","first-page":"340","DOI":"10.5853\/jos.2016.01424","article-title":"Visibility of CT early ischemic change is significantly associated with time from stroke onset to baseline scan beyond the first 3 h of stroke onset","volume":"19","author":"Gao","year":"2017","journal-title":"J. Stroke"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.3389\/fphar.2020.01007","article-title":"The risk of arterial thrombosis in patients with chronic myeloid leukemia treated with second and third generation BCR-ABL tyrosine kinase inhibitors may be explained by their impact on endothelial cells: an in-vitro study","volume":"11","author":"Haguet","year":"2020","journal-title":"Front. Pharmacol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1159\/000330462","article-title":"The ischemic penumbra: correlates in imaging and implications for treatment of ischemic Stroke: the Johann Jacob Wepfer Award 2011","volume":"32","author":"Heiss","year":"2011","journal-title":"Cerebrovasc. Dis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1007\/s00701-021-05043-3","article-title":"New-generation tyrosine kinase inhibitor-associated asymptomatic cerebrovascular stenosis: two illustrative cases","volume":"164","author":"Hirayama","year":"2022","journal-title":"Acta Neurochir."},{"key":"B8","doi-asserted-by":"publisher","first-page":"83","DOI":"10.14740\/jh519","article-title":"Large vessel vasculitis as a possible mechanism of vascular side effects of ponatinib: a case report","volume":"8","author":"Hirschbuehl","year":"2019","journal-title":"J. Hematol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"105883","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.105883","article-title":"Nilotinib-associated atherosclerosis presenting as multifocal intracranial stenosis and acute stroke","volume":"30","author":"Kakadia","year":"2021","journal-title":"J. Stroke Cerebrovasc. Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1212\/01.wnl.0000314686.94007.d0","article-title":"Anterior cerebral artery infarction: stroke mechanism and clinical-imaging study in 100 patients","volume":"70","author":"Kang","year":"2008","journal-title":"Neurology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1111\/ene.12202","article-title":"High resolution MRI difference between moyamoya disease and intracranial atherosclerosis","volume":"20","author":"Kim","year":"2013","journal-title":"Eur. J. Neurol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"307","DOI":"10.2176\/jns-nmc.2022-0072","article-title":"Diagnostic criteria for moyamoya disease-2021 revised version","volume":"62","author":"Kuroda","year":"2022","journal-title":"Neurol. Med. Chir."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1161\/STROKEAHA.122.041932","article-title":"Five-year stroke risk and its predictors in asymptomatic moyamoya disease: Asymptomatic Moyamoya Registry (AMORE)","volume":"54","author":"Kuroda","year":"2023","journal-title":"Stroke"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jcm9030820","article-title":"Ponatinib induces vascular toxicity through the notch-1 signaling pathway","volume":"9","author":"Madonna","year":"2020","journal-title":"J. Clin. Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1161\/ATVBAHA.119.313353","article-title":"Tyrosine kinase inhibitors in leukemia and cardiovascular events: from mechanism to patient care","volume":"40","author":"Manouchehri","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"4210","DOI":"10.1200\/JCO.2015.62.4718","article-title":"Tyrosine kinase inhibitor-associated cardiovascular toxicity in chronic myeloid leukemia","volume":"33","author":"Moslehi","year":"2015","journal-title":"J. Clin. Oncol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1161\/CIRCULATIONAHA.118.038439","article-title":"Moyamoya disease susceptibility variant RNF213 p.R4810K increases the risk of ischemic stroke attributable to large-artery atherosclerosis","volume":"139","author":"Okazaki","year":"2019","journal-title":"Circulation"},{"key":"B18","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.jbmt.2011.11.002","article-title":"Comparison of Brunnstrom movement therapy and motor relearning program in rehabilitation of post-stroke hemiparetic hand: a randomized trial","volume":"16","author":"Pandian","year":"2012","journal-title":"J. Bodyw. Mov. Ther"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1161\/STROKEAHA.120.029076","article-title":"Functional neurological disorder","volume":"51","author":"Popkirov","year":"2020","journal-title":"Stroke"},{"key":"B20","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2176\/jns-nmc.2022-0298","article-title":"Tyrosine kinase inhibitor-associated cerebral arterial occlusive disease treated with high-flow bypass surgery: a case report","volume":"10","author":"Rai","year":"2023","journal-title":"NMC Case Rep. J"},{"key":"B21","doi-asserted-by":"publisher","first-page":"706","DOI":"10.3389\/fimmu.2018.00706","article-title":"Vasa vasorum angiogenesis: key player in the initiation and progression of atherosclerosis and potential target for the treatment of cardiovascular disease","volume":"9","author":"Sedding","year":"2018","journal-title":"Front. Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"105085","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105085","article-title":"Progressive thrombosis of cervical and intracranial arteries related to Ponatinib treatment for Chronic Myeloid Leukemia","volume":"29","author":"Spina","year":"2020","journal-title":"J. Stroke Cerebrovasc. Dis"},{"key":"B23","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3892\/mco.2018.1780","article-title":"Vessel wall magnetic resonance imaging findings and surgical treatment in nilotinib-associated cerebrovascular disease: a case report","volume":"10","author":"Suzuki","year":"2019","journal-title":"Mol. Clin. Oncol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"116577","DOI":"10.1016\/j.jns.2019.116577","article-title":"Role of RNF213 p.4810K variant in the development of intracranial arterial disease in patients treated with nilotinib","volume":"408","author":"Uemura","year":"2020","journal-title":"J. Neurol. Sci"},{"key":"B25","doi-asserted-by":"publisher","first-page":"110455","DOI":"10.1016\/j.ejrad.2022.110455","article-title":"Associations between early ischemic signs on non-contrast CT and time since acute ischemic stroke onset: a scoping review","volume":"155","author":"van Poppel","year":"2022","journal-title":"Eur. J. Radiol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"87","DOI":"10.21037\/atm.2019.12.140","article-title":"High-resolution combined arterial spin labeling MR for identifying cerebral arterial stenosis induced by moyamoya disease or atherosclerosis","volume":"8","author":"Ya","year":"2020","journal-title":"Ann. Transl. Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/ccd.28189","article-title":"Tyrosine kinase inhibitor toxicity manifesting as comorbid Moyamoya syndrome and obstructive coronary artery disease: a case report and review of the literature","volume":"94","author":"Zhuo","year":"2019","journal-title":"Catheter. Cardiovasc. Interv"}],"container-title":["Frontiers in Stroke"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fstro.2024.1367869\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T04:37:08Z","timestamp":1712119028000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fstro.2024.1367869\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,3]]},"references-count":27,"alternative-id":["10.3389\/fstro.2024.1367869"],"URL":"https:\/\/doi.org\/10.3389\/fstro.2024.1367869","relation":{},"ISSN":["2813-3056"],"issn-type":[{"value":"2813-3056","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,3]]},"article-number":"1367869"}}